Valens Company gains access to GMP manufacturing in Australia
The company will utilise a licensed medicinal cannabis manufacturing facility with TGA and EU GMP capabilities in Southport, Queensland Australia, run by THC Pharma, an Epsilon Healthcare subsidiary